Abbott Laboratories/ US0028241000 /
11/12/2024 9:52:29 PM | Chg. -0.10 | Volume | Bid11/12/2024 | Ask11/12/2024 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
116.70USD | -0.09% | 2.13 mill. Turnover: 173.9 mill. |
116.69Bid Size: 400 | 116.71Ask Size: 1,000 | 202.61 bill.USD | 1.78% | 35.61 |
Assets
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 5,730 | 5,705 | 7,607 | 7,563 | 8,038 | ||||||
Intangible Assets | 5,562 | 4,539 | 21,473 | 18,942 | 17,025 | ||||||
Long-Term Investments | 4,041 | 2,947 | 883 | 897 | 883 | ||||||
Fixed Assets | 27,092 | 25,890 | 56,103 | 52,541 | 52,220 | ||||||
Inventories | 2,599 | 2,434 | 3,601 | 3,796 | 4,316 | ||||||
Accounts Receivable | 3,418 | 3,248 | 5,249 | 5,182 | 5,425 | ||||||
Cash and Cash Equivalents | 5,001 | 18,620 | 9,407 | 3,844 | 3,860 | ||||||
Current Assets | 14,155 | 26,776 | 20,147 | 14,632 | 15,667 | ||||||
Total Assets | 41,247 | 52,666 | 76,250 | 67,173 | 67,887 |
Liabilities
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 1,081 | 1,178 | 2,402 | 2,975 | 3,252 | ||||||
Long-term debt | 5,871 | 20,681 | 27,210 | 19,359 | 16,661 | ||||||
Liabilities to Banks | 3,127 | 1,322 | 206 | 200 | 201 | ||||||
Provisions | 430 | 188 | 309 | 305 | 226 | ||||||
Liabilities | 19,921 | 31,949 | 45,152 | 36,451 | 36,586 | ||||||
Share Capital | 12,734 | 13,027 | 23,206 | 23,512 | 23,853 | ||||||
Total Equity | 21,326 | 20,717 | 31,098 | 30,722 | 31,301 | ||||||
Minority Interests | 115 | 179 | 201 | 198 | 213 | ||||||
Total liabilities equity | 41,247 | 52,666 | 76,250 | 67,173 | 67,887 |
Income Statement
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 20,405 | 20,853 | 27,390 | 30,578 | 31,904 | ||||||
Depreciation (total) | 1,472 | 1,353 | 3,021 | 3,278 | 3,014 | ||||||
Operating Result | 2,867 | 3,185 | 1,726 | 3,650 | 4,532 | ||||||
Interest Income | -58 | -332 | -780 | -721 | -576 | ||||||
Income Before Taxes | 3,183 | 1,413 | 2,231 | 2,873 | 4,077 | ||||||
Income Taxes | 577 | 350 | 1,878 | 539 | 390 | ||||||
Minority Interests Profit | - | - | - | - | - | ||||||
Net Income | 4,423 | 1,400 | 477 | 2,368 | 3,687 |
Per Share
Cash Flow
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 2,966 | 3,203 | 5,570 | 6,300 | 6,136 | ||||||
Cash Flow from Investing Activities | 406 | -248 | -9,618 | -1,356 | -1,815 | ||||||
Cash Flow from Financing | -2,236 | 11,147 | -5,281 | -10,391 | -4,289 | ||||||
Decrease / Increase in Cash | 938 | 13,619 | -9,213 | -5,563 | 16 | ||||||
Employees | 74,000 | 75,000 | 99,000 | 103,000 | 107,000 |